Cannabis compound tested as a way to soften painful memories

NCT ID NCT06471647

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This early-phase trial investigates whether delta-9-tetrahydrocannabinol (THC), the main psychoactive compound in cannabis, can reduce the emotional and physical responses triggered by recalling stressful experiences. Healthy adults aged 18–35 with some prior cannabis use will receive either a low or moderate dose of THC or a placebo before being exposed to cues linked to a stressful memory. Researchers will measure self-reported distress and heart-related responses to see if THC dampens the reaction, both immediately and one week later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
delta-9-tetrahydrocannabinol (THC)
What this could lead to
If THC dampens the emotional sting of bad memories, it could point toward a new way to treat conditions like PTSD.
What could go wrong
This is a very early, small study in healthy volunteers, so results may not apply to people with mental health conditions. THC can also cause anxiety or paranoia in some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELTA-9-TETRAHYDROCANNABINOL (THC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Chicago

    Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.